Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis
- PMID: 27548822
- DOI: 10.1159/000447276
Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis
Abstract
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver diseases from simple steatosis with hepatic lipid accumulation to end-stage liver disease with decompensated cirrhosis, liver failure and hepatocellular carcinoma. Recent data from the USA showed that in 2013, NAFLD was the second most frequent indication for liver transplantation behind hepatitis C. Since there are now effective treatments for hepatitis C and there is currently no licensed treatment for NAFLD, it has been predicted that over the next 10-15 years, NAFLD will replace hepatitis C as the most frequent indication for liver transplantation. Besides, increasing the risk of hepatocellular carcinoma and end-stage liver disease, it has recently become clear that NAFLD also increases risk of extrahepatic diseases such as type 2 diabetes mellitus (T2DM), cardiovascular disease, cardiac diseases and chronic kidney disease, to name but a few. Of each of these extrahepatic diseases, the evidence to date suggests that NAFLD is a strong risk factor for T2DM. When NAFLD occurs in combination with obesity and insulin resistance (as it frequently does), there is a marked increase in risk of incident T2DM with possible synergism occurring between liver fat accumulation, insulin resistance and obesity to further increase risk of development of T2DM. Thus, there is a reciprocal relationship between NAFLD as a risk factor for T2DM, and T2DM as a risk factor for liver disease progression in NAFLD. Moreover, recent evidence now points to the importance of perturbation of the intestinal microbiota (dysbiosis) in both T2DM and NAFLD. Consequently, there is a triangular relationship between dysbiosis and T2DM and NAFLD. This review will focus on T2DM as a key extrahepatic complication of NAFLD and will describe and discuss the triangular relationship between dysbiosis and T2DM and NAFLD and the factors and potential mechanisms underpinning this relationship.
© 2016 S. Karger AG, Basel.
Similar articles
-
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17. Gut. 2017. PMID: 28314735 Review.
-
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Nat Rev Nephrol. 2017 May;13(5):297-310. doi: 10.1038/nrneph.2017.16. Epub 2017 Feb 20. Nat Rev Nephrol. 2017. PMID: 28218263 Review.
-
NAFLD: a multisystem disease.J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012. J Hepatol. 2015. PMID: 25920090 Review.
-
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103. World J Gastroenterol. 2015. PMID: 25892859 Free PMC article. Review.
-
NAFLD and diabetes mellitus.Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):32-42. doi: 10.1038/nrgastro.2016.147. Epub 2016 Oct 12. Nat Rev Gastroenterol Hepatol. 2017. PMID: 27729660 Review.
Cited by
-
REV-ERB agonism improves liver pathology in a mouse model of NASH.PLoS One. 2020 Oct 1;15(10):e0236000. doi: 10.1371/journal.pone.0236000. eCollection 2020. PLoS One. 2020. PMID: 33002003 Free PMC article.
-
MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis.Front Med (Lausanne). 2022 Jan 13;8:774079. doi: 10.3389/fmed.2021.774079. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35096868 Free PMC article. Review.
-
Anthropometric Indices and Type 2 Diabetes Mellitus as a Risk Factor in Predicting Nonalcoholic Fatty Liver Disease - A Prospective Study in Indian Population.Indian J Community Med. 2022 Jul-Sep;47(3):386-390. doi: 10.4103/ijcm.ijcm_1213_21. Epub 2022 Oct 10. Indian J Community Med. 2022. PMID: 36438527 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus.Cureus. 2021 Aug 20;13(8):e17321. doi: 10.7759/cureus.17321. eCollection 2021 Aug. Cureus. 2021. PMID: 34557367 Free PMC article. Review.
-
Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia.J Korean Med Sci. 2020 Jun 8;35(22):e164. doi: 10.3346/jkms.2020.35.e164. J Korean Med Sci. 2020. PMID: 32508064 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
